Gujarat-based SAVA Healthcare recently conducted the ground-breaking ceremony for its upcoming cutting-edge manufacturing facility in Indore. The company’s second manufacturing plant will be developed over an impressive 13.8 Acres of land in SIP (Smart Industrial Park) of MPIDC (Madhya Pradesh Industry Development Corporation).
The greenfield project will be developed in two phases with phase I slated for completion within 12 months and phase II to be completed by 2026. The first phase will have a built-up area of nearly 29,000 SqM, whereas it will have an annual production capacity of 2351.3 Million SKUs. These include tablets, capsules, dry powder for oral suspensions, nasal sprays, and dry powder.
Also Read: Upcoming ultra-luxury residential project – Aparna Aqua, Hyderabad
The forthcoming facility will adhere to stringent regulatory standards such as EuGMP (European Good Manufacturing Practice) and USFDA (United States Food and Drug Administration) requirements. It will cater to the growing demand for quality pharmaceuticals both in India and globally.
Biltrax Construction Data is tracking 30,000+ projects on their technology platform for their clients.
Get exclusive access to upcoming projects in India with actionable insights. Furthermore, gain a competitive advantage for your products in the Indian Construction Market.
Visit www.biltrax.com or email us at contact@biltrax.com to become a subscriber and generate leads.
Disclaimer: The information herein is based upon information obtained in good faith from sources believed to be reliable. All such information and opinions can be subject to change. Furthermore, The image featured in this article is for representation purposes only and does not in any way represent the project. If you wish to remove or edit the article, please email editor@biltrax.com.
1
